Arif Osman TOKAT, Cabir YÜKSEL, Adem GÜNGÖR, Özdemir Özlem KUMBASAR

Kombine küçük hücreli ve büyük hücreli akciğer kanseri ile Lambert-Eaton miyastenik sendromu birlikteliği: Olgu sunumu

Lambert-Eaton miyastenik sendromu (LEMS) nadir görülen bir nöromusküler iletim bozukluğudur. Akciğer karsinomları ile ilişkili olan hastalığın temelinde otoimmün mekanizmalar yatmaktadır. Günümüzde sık rastlanan ve mortal seyreden hastalıklar arasında olan akciğer kanserlerinin semptomları arasında oldukça seyrek de olsa LEMS'ye rastlanabilmektedir. Burada sunduğumuz olgu, akciğer kanseri semptomlarından önce LEMS semptomları sebebiyle tetkik edilerek, pulmoner arter komşuluğunda tümör saptanan bir olgudur. Olgu erken tanı ile tedavi şansı bulmuştur.

Association of combined small cell and large cell lung cancer with Lambert-Eaton myasthenic syndrome: case report

Lambert-Eaton myasthenic syndrome (LEMS) is a rare type of neuromusculer conduction disorder. This disease can be seen with lung cancer and, it is associated with otoimmunity. Among the symptoms of lung cancer LEMS can be seen, but it is very rare. In this case, LEMS symptoms were analyzed before lung cancer symptoms. The localization of the tumor was near the pulmonary artery. By the early diagnose, the patient had the chance of cure.

PDF

___

1. Victor M, Allan HR. Myastenia gravis and related disorders of the neuromuscular junction. In: Adams and Victor's Principles of Neurology. 7th ed. New York: McGrawHill Co., 2001: 1536-52.
2. Kleopa KA, Teener JW, Scherer SS, et al. Chronic multiple paraneoplastic syndromes. Muscle Nerve 2000; 23:1767-72.
3. Meriney SD, Nulsizer SC, Lennon VA, Grinnell AD. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung carcinoma. Ann Neurol 1996; 40: 739-49.
4. Motomura M, Hamasaki S, Nakane S, et al. Apheresis treatment in Lambert-Eaton myasthenic syndrome. The Apher 2000; 4: 287-90.
5. Fushimi H, Kikui M, Morino H, et al. Histologic changes in small cell lung carcinoma after treatment. Cancer 1996; 77: 278-83.
6. Parsons KT, Kwok WW, Gaur LK, Nepom GT. Increased frequency of HLA class II alleles DRBl*0301 and DQB1 *0201 in Lambert-Eaton myasthenic syndrome without associated cancer. Hum Immunol 2000; 61: 828-33.
7. Tim RW, Massey JM, Sanders DB. Lambert- Eaton myast-henig syndrome: electrodiagnostic findings and response to treatment.Neurology 2000;54:2176-8.
8. Demirer T, Ravits J, Abolulafia D. Myasthenic (Eaton Lambert) syndrome associated with pulmonary large-cell neuroendocrine carcinoma. South Med J 1994; 87: 1186-9.